Pulkit Gupta is an experienced pharmaceutical professional currently serving as the Executive Director at Lilly Ventures and holding positions as a Board Observer at HiberCell, Mariana Oncology, Crossbow Therapeutics, and Orbis Medicines. With a strong background in small molecule and antibody discovery, Pulkit contributed to the development of Zinplava (Bezlotoxumab) during their tenure at Merck. They received a Ph.D. in Pharmaceutical Biotechnology from the University of Illinois at Chicago, where they also conducted graduate research on molecular mechanisms of protein synthesis in bacteria. Pulkit has demonstrated a collaborative attitude and proficiency in communicating scientific data throughout their career.
This person is not in any teams
This person is not in any offices